Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Arteriosclerosis, Thrombosis and Vascular Biology

• Publication date

  2000-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.ATV.20.8.2019PMID 10938026
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• HEMOSTATIC FACTORS AND THE RISK OF MYOCARDIAL INFARCTION OR SUDDEN DEATH IN PATIENTS WITH ANGINA PECTORIS

  2001cited by this paper
• Higher relative, but lower absolute risks of myocardial infarction in women than in men: analysis of some major risk factors in the S heep study

  1999cited by this paper
• Factor VIII, von Willebrand factor and the risk of major ischaemic heart disease in the Caerphilly Heart Study

  1999cited by this paper
• Higher relative, but lower absolute risks of myocardial infarction in women than in men: analysis of some major risk factors in the SHEEP study. The SHEEP Study Group.

  1999cited by this paper
• Tissue plasminogen activator (tPA) antigen in plasma: correlation with different tPA/inhibitor complexes.

  1998cited by this paper
• Fibrinolytic variables and cardiovascular prognosis in patients with stable angina pectoris treated with verapamil or metoprolol. Results from the Angina Prognosis study in Stockholm.

  1997cited by this paper
• Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.

  1995cited by this paper
• Involvement of the hemostatic system in the insulin resistance syndrome. A study of 1500 patients with angina pectoris. The ECAT Angina Pectoris Study Group.

  1993cited by this paper
• Endogenous tissue-type plasminogen activator and risk of myocardial infarction.

  1993cited by this paper
• Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients. A case-control study. The PLAT Group.

  1993cited by this paper
• Predictive Value of Tissue Plasminogen Activator Mass Concentration on Long‐term Mortalit in Patients With Coronary Artery Disease A 7‐Year Follow‐up

  1993cited by this paper
• von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death

  1992cited by this paper
• von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death.

  1991cited by this paper
• Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis

  1991cited by this paper
• Tissue plasminogen activator and other risk factors as predictors of cardiovascular events in patients with severe angina pectoris.

  1991cited by this paper
• Elevated fibrinogen and plasminogen activator inhibitor (PAI‐1) in hypertension are related to metabolic risk factors for cardiovascular disease

  1990cited by this paper
• Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1.

  1990cited by this paper
• Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction.

  1987cited by this paper
• Relationships between plasma insulin triglyceride, body mass index, and plasminogen activator inhibitor 1.

  1987cited by this paper
• Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction.

  1985cited by this paper

• Residual cardiovascular risk in coronary artery disease: from pathophysiology to established and novel therapies.

  2026cites this paper
• Urine and Serum Biomarkers of Cardiovascular Status and Early Vascular Ageing in Children and Adults

  2025cites this paper
• HISTORICAL REVIEW: MORE THAN TWO DECADES UNDERSTANDING THE GENETIC ARCHITECTURE OF HEMOSTASIS AND THROMBOSIS.

  2025cites this paper
• Methods, precision, and analytical sensitivity of a novel low‐plasma‐volume assay of fibrinolytic capacity utilizing the euglobulin fraction

  2024cites this paper
• Aging Is Associated With Organ-Specific Alterations in the Level and Expression Pattern of von Willebrand Factor

  2023influential citation
• Ustekinumab reduces serum protein levels associated with cardiovascular risk in psoriasis vulgaris

  2022cites this paper
• A first‐in‐human study of the anti‐inflammatory profibrinolytic TMS‐007, an SMTP family triprenyl phenol

  2022cites this paper
• Vascular Implications of COVID-19: Role of Radiological Imaging, Artificial Intelligence, and Tissue Characterization: A Special Report

  2022cites this paper
• Global REACH 2018: Influence of excessive erythrocytosis on coagulation and fibrinolytic factors in Andean highlanders

  2021cites this paper
• Serum anti-SERPINE1 antibody as a potential biomarker of acute cerebral infarction

  2021cites this paper
• Headache in Children: Selected Factors of Vascular Changes Involved in Underlying Processes of Idiopathic Headaches

  2020cites this paper
• The effects of hydration status on cardiovascular system: a review

  2020cites this paper
• Novel Biomarkers, ST‐Elevation Resolution, and Clinical Outcomes Following Primary Percutaneous Coronary Intervention

  2020cites this paper
• Covid-19-associated coagulopathy (CoAC): thrombin burst and insufficient fibrinolysis leading to bad outcome.

  2020cites this paper
• Proteomic biomarkers of sleep apnea.

  2020cites this paper
• Snake venom‐derived bradykinin‐potentiating peptides: A promising therapy for COVID‐19?

  2020cites this paper
• Platelet counts are associated with arterial stiffness in Chinese Han population: a longitudinal study

  2020cites this paper
• Covid-19-Associated Coagulopathy: Biomarkers of Thrombin Generation and Fibrinolysis Leading the Outcome

  2020cites this paper
• A Review of the Role of Bradykinin and Nitric Oxide in the Cardioprotective Action of Angiotensin-Converting Enzyme Inhibitors: Focus on Perindopril

  2019cites this paper
• Plasminogen activator inhibitor‐1 augments damage by impairing fibrinolysis after traumatic brain injury

  2019cites this paper
• Plasminogen activator inhibitor 1 in acute coronary syndromes.

  2019cites this paper
• Association between plasminogen activator inhibitor-1 and cardiovascular events: a systematic review and meta-analysis

  2018cites this paper
• Relationships between markers of neurologic and endothelial injury during critical illness and long-term cognitive impairment and disability

  2018cites this paper
• DNA methylation age is associated with an altered hemostatic profile in a multiethnic meta-analysis.

  2018cites this paper
• Treadmill exercise alleviates diabetic cardiomyopathy by suppressing plasminogen activator inhibitor expression and enhancing eNOS in streptozotocin-induced male diabetic rats

  2018cites this paper
• Determination of plasminogen/plasmin system components and indicators of lipoproteins oxidative modification under arterial hypertension

  2018cites this paper
• Plasminogen Activator Inhibitor-1 Promotes Neutrophil Infiltration and Tissue Injury on Ischemia–Reperfusion

  2018cites this paper
• Tissue-type plasminogen activator regulates macrophage activation and innate immunity.

  2017cites this paper
• Endothelial cell markers from clinician's perspective.

  2017cites this paper
• Thrombosis and von Willebrand Factor.

  2016cites this paper
• Pharmacological stimulation of endothelial function and long-term impact of hypertension in man

  2016cites this paper
• Thyroid Function Within the Reference Range and the Risk of Stroke: An Individual Participant Data Analysis.

  2016cites this paper
• Von Willebrand Factor and ADAMTS13 in Cardiovascular Disease

  2016cites this paper
• Fibrinolytic effects of peroneal nerve stimulation in patients with lower limb vascular disease

  2016cites this paper
• Unraveling the Pivotal Role of Bradykinin in ACE Inhibitor Activity

  2016cites this paper
• Markers of fibrinolysis may predict development of lower extremity arterial disease in patients with diabetes: A longitudinal prospective cohort study with 10 years of follow-up

  2016cites this paper
• Hematological Risk Factors for Coronary Heart Disease

  2016cites this paper
• Diabetes Mellitus and Cardiovascular Risk : epidemiology, etiology and intervention

  2016cites this paper
• Subclinical Hypothyroidism and the Risk of Stroke Events and Fatal Stroke: An Individual Participant Data Analysis.

  2015cites this paper
• Long- and Short-term Exposure to Air Pollution and Inflammatory/Hemostatic Markers in Midlife Women

  2015cites this paper
• Insulin resistance: an additional risk factor in the pathogenesis of cardiovascular disease in type 2 diabetes

  2015cites this paper
• The association of clot lysis time with total obesity is partly independent from the association of PAI-1 with central obesity in African adults.

  2015cites this paper
• BDNFVal66met polymorphism: a potential bridge between depression and thrombosis

  2015cites this paper
• Von Willebrand factor and ADAMTS13 in arterial thrombosis: a systematic review and meta-analysis.

  2014cites this paper
• Genome-Wide Association Study for Circulating Tissue Plasminogen Activator Levels and Functional Follow-Up Implicates Endothelial STXBP5 and STX2

  2014cites this paper
• Profibrinolytic Effect of the Epigenetic Modifier Valproic Acid in Man

  2014cites this paper
• Endothelial Dysfunction and Cerebral Blood Flow

  2014cites this paper
• The association between fibrinolysis markers and body composition in black adults in the North West Province of South Africa

  2014cites this paper
• Fibrinolytic factors in relation to anthropometry and incident type 2 diabetes.

  2014cites this paper
• New pathway for tissue-type plasminogen activator regulation.

  2014cites this paper
• Resistin regulates the expression of plasminogen activator inhibitor-1 in 3T3-L1 adipocytes.

  2014cites this paper
• The in vitro effects of sodium salicylate on von Willebrand factor and C-reactive protein production by endothelial cells

  2014cites this paper
• vonWillebrand Factor and Oxidative Stress Parameters in Acute Coronary Syndromes

  2014cites this paper
• The Role of Plasminogen Activator Inhibitor-1 in the Metabolic Syndrome and Its Regulation

  2014influential citation
• Cardiovascular and hemodynamic contribution to brain aging

  2014cites this paper
• A case report of acute right coronary artery thrombosis in young male: the role of heredity and genetic polymorphism.

  2014cites this paper
• Secretion of von Willebrand factor by endothelial cells links sodium to hypercoagulability and thrombosis

  2014cites this paper
• Potential value of targeting von Willebrand factor in atherosclerotic cardiovascular disease

  2014cites this paper
• Markers of endothelial dysfunction and cerebral blood flow in older adults.

  2014cites this paper
• Composition of PM Affects Acute Vascular Inflammatory and Coagulative Markers - The RAPTES Project

  2013cites this paper
• In vitro studies using a global hemostasis assay to examine the anticoagulation effects in plasma by the direct thrombin inhibitors: dabigatran and argatroban

  2013cites this paper
• Job insecurity and prognosis after myocardial infarction: the SHEEP Study.

  2013cites this paper
• Cardiometabolic Risk Factors in Children

  2013cites this paper
• Hemostasis and microvascular function in type 1 diabetes : effects of treatment with statin and aspirin

  2013cites this paper
• cells modulation by plasminogen activator inhibitor-1 in vascular endothelial Unique secretory dynamics of tissue plasminogen activator and its

  2013cites this paper
• Differential effects of long chain omega-3 polyunsaturated fatty acids on platelet aggregation and hemostatic variables in healthy male versus female subjects

  2013cites this paper
• von Willebrand factor: at the crossroads of bleeding and thrombosis

  2012cites this paper
• Endogenous hypercorticism as a prothrombogenic state

  2012cites this paper
• Signs of dysregulated fibrinolysis precede the development of type 2 diabetes mellitus in a population-based study

  2012cites this paper
• Haemostatic and inflammatory markers are independently associated with myocardial infarction in men and women.

  2012cites this paper
• Whole grain wheat sourdough bread does not affect plasminogen activator inhibitor-1 in adults with normal or impaired carbohydrate metabolism.

  2012cites this paper
• Determinants of adverse events during oral anticoagulant treatment

  2012cites this paper
• Impaired fibrinolytic capacity and increased fibrin formation associate with myocardial infarction

  2012cites this paper
• Pioglitazone suppresses advanced glycation end product-induced expression of plasminogen activator inhibitor-1 in vascular smooth muscle cells.

  2011cites this paper
• Prothrombotic profile in patients with vasospastic or non vasospastic angina and non significant coronary stenosis

  2011influential citation
• Statement From the American Heart Association Mechanistic, Research, and Clinical Considerations for Youth : A Scientific Nontraditional Risk Factors and Biomarkers for Cardiovascular Disease:

  2011cites this paper
• The in vitro effect of the new antithrombotic drug candidate ALX-0081 on blood samples of patients undergoing percutaneous coronary intervention

  2011cites this paper
• The anti-fibrinolytic SERPIN, plasminogen activator inhibitor 1 (PAI-1), is targeted to and released from catecholamine storage vesicles.

  2011cites this paper
• Plasminogen Activator Inhibitor 1 (Pai-1) as an Adipokine

  2011cites this paper
• Discovery of inhibitors of plasminogen activator inhibitor-1: structure-activity study of 5-nitro-2-phenoxybenzoic acid derivatives.

  2011cites this paper
• Prospective study of the incidence and predictors of thrombus in children undergoing palliative surgery for single ventricle physiology

  2011cites this paper
• Nontraditional Risk Factors and Biomarkers for Cardiovascular Disease: Mechanistic, Research, and Clinical Considerations for Youth A Scientific Statement From the American Heart Association

  2011cites this paper
• von Willebrand Factor and Oxidative Stress Parameters in Acute Coronary Syndromes

  2011cites this paper
• Prothrombotic markers in asymptomatic dyslipidemic subjects

  2010cites this paper
• Diabetes is a proinflammatory state: a translational perspective

  2010cites this paper
• ADAMTS13 in arterial thrombosis

  2010cites this paper
• University of Groningen Cardiovascular Risk Associated with Interactions among Polymorphisms in Genes from the Renin-Angiotensin, Bradykinin, and Fibrinolytic Systems

  2010cites this paper
• Molecular aspects in clinical hemostasis research at Karolinska Institutet.

  2010cites this paper
• Uridine triphosphate (UTP) induces profibrotic responses in cardiac fibroblasts by activation of P2Y2 receptors.

  2010cites this paper
• Associations of Thrombotic-Hemostatic Factors with Cardiovascular Disease~!2009-10-29~!2009-12-22~!2010-04-08~!

  2010cites this paper
• Characterization of a Novel Class of Polyphenolic Inhibitors of Plasminogen Activator Inhibitor-1*

  2010cites this paper
• The effect of chronic kidney disease on fibrin clot properties in patients with acute coronary syndrome

  2010cites this paper
• Effects of carvedilol or metoprolol on PAI-1, tPA-mass concentration or Von Willebrand factor in chronic heart failure--a COMET substudy.

  2010cites this paper
• The prognostic value of biomarkers after a premature myocardial infarction.

  2010cites this paper
• Palmitate and insulin synergistically induce IL-6 expression in human monocytes

  2010cites this paper
• ADIPOCYTE-DERIVED HORMONES AND CARDIOVASCULAR DISEASE

  2010cites this paper
• Cardiovascular Risk Associated with Interactions among Polymorphisms in Genes from the Renin-Angiotensin, Bradykinin, and Fibrinolytic Systems

  2010cites this paper
• Biomarkers for outcomes following acute coronary syndromes

  2010cites this paper
• The role of the fibrinolytic system in arterial and venous thrombosis

  2010cites this paper
• Hypertension and hemostatic/fibrinolytic balance disorders.

  2009cites this paper